SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Progress Note 7 — Preventive Visit — Mahalia Jackson — True-date frame: synthetic events are moved into the patient's historical lifetime. Codes, instruments, and treatments remain modern and are anachronistic.

PatientMahalia Jackson
Date of birth1911-10-26
IdentifiersMRN HR-ML035-SYN-TD; SSN (made up) 000-35-4692
Document date1964-10-05
AuthorBeatrice Fontenot, MD
CustodianSt. Posthumous Health Center

Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.

Chief Complaint

Periodic adult preventive visit. [S]

History of Present Illness

Ms. Jackson, 52, comes for her yearly preventive visit six weeks after the review at which the repeat FDG-PET showed no active heart inflammation. Prednisone was reduced to 7.5 mg two weeks ago as planned; she takes methotrexate 20 mg weekly with folic acid, metoprolol, alendronate and vitamin D. She has more energy, climbs two flights of stairs without stopping, and has sung two concerts a week since the spring, with a longer tour planned for later in the autumn. The hoarseness in June settled within ten days. Her defibrillator has given no shocks, and the remote check last month was normal. She sleeps well now that the prednisone dose is lower. Her PHQ-9 today is 3. [S]

ElementDetail
VisitPeriodic adult preventive visit, age 52
Active conditionsPulmonary and cardiac sarcoidosis in remission on treatment; dual-chamber defibrillator; long-term glucocorticoids
MedicinesPrednisone 7.5 mg daily; methotrexate 20 mg weekly with folic acid 1 mg daily; metoprolol succinate 25 mg; alendronate 70 mg weekly; cholecalciferol 1000 units daily
MoodPHQ-9 3

Health risk assessment. Completed on paper in the waiting room and reviewed with her by Dr. Fontenot. [S]

DomainFinding
Self-rated healthGood, and much better than in the winter
PsychosocialFaith and her church community are her strength; touring is tiring but is her purpose; worried about money while concerts were cancelled
TobaccoNever smoked
Alcohol and drugsNo alcohol (she avoids it on methotrexate) and no drugs
Physical activityWalks 30 minutes most days at home; less on tour
NutritionHome cooking at home; irregular meals on tour; has cut down on sweet drinks since her A1c rose; no calcium tablets, dairy twice a day
SleepSeven hours since the prednisone was lowered
Safety at homeFeels safe; no one hurts, threatens or controls her
Road safetyWears a seat belt; driven on tour
FallsNo falls
Activities of daily livingIndependent

Review of Systems

SystemResultFinding
ConstitutionalNegativeEnergy better; no fever, night sweats or weight change
EyesNegativeNo redness, pain, blurred vision or floaters
Ears, nose, mouth, and throatNegativeVoice back to normal; no mouth sores
CardiovascularNegativeNo chest pain, palpitations, fainting or device shocks
RespiratoryNegativeBreathless only on hills; no cough
GastrointestinalNegativeNo heartburn with alendronate; no change in bowel habit or blood
GenitourinaryNegativeNo urinary symptoms or vaginal bleeding
BreastNegativeNo lump, skin change or nipple discharge
MusculoskeletalNegativeNo bone pain or joint swelling
IntegumentaryNegativeNo rash, nodules or skin plaques; easy bruising less now
NeurologicalNegativeNo numbness, weakness or headache
EndocrineNegativeNo thirst or frequent urination
PsychiatricNegativeMood good; PHQ-9 3; no thoughts of self-harm

13 systems reviewed. [S]

Medications

MedicationFrequencyRouteDatesStatusEvidence
Prednisone 20 mg oral tablet, two tablets (40 mg) by mouth each morning40 mg each morningOral route1964-03-09 to 1964-05-11completedS
Prednisone 10 mg oral tablet, three tablets (30 mg) by mouth each morning for four weeks30 mg each morning for four weeksOral route1964-05-11 to 1964-06-08completedS
Prednisone 20 mg oral tablet, one tablet (20 mg) by mouth each morning for four weeks20 mg each morning for four weeksOral route1964-06-08 to 1964-07-06completedS
Prednisone 5 mg oral tablet, three tablets (15 mg) by mouth each morning for four weeks15 mg each morning for four weeksOral route1964-07-06 to 1964-08-03completedS
Prednisone 10 mg oral tablet, one tablet (10 mg) by mouth each morning10 mg each morningOral route1964-08-03 to 1964-09-21completedS
Prednisone 5 mg oral tablet, one and a half tablets (7.5 mg) by mouth each morning7.5 mg each morningOral route1964-09-21activeS
Methotrexate 2.5 mg oral tablet, six tablets (15 mg) by mouth once a week on Sundays15 mg once weeklyOral route1964-03-09 to 1964-05-11completedS
Methotrexate 2.5 mg oral tablet, eight tablets (20 mg) by mouth once a week on Sundays20 mg once weeklyOral route1964-05-11activeS
Folic acid 1 mg oral tablet, one tablet by mouth dailyOne tablet dailyOral route1964-03-09activeS
Atovaquone 750 mg/5 mL oral suspension, 1500 mg (10 mL) by mouth once daily with food1500 mg once daily with foodOral route1964-03-09 to 1964-07-06completedS
Alendronate 70 mg oral tablet, one tablet by mouth once weekly on rising, with a full glass of water, staying upright for 30 minutesOne tablet once weeklyOral route1964-03-16activeS
Metoprolol succinate 25 mg extended-release oral tablet, one tablet by mouth dailyOne tablet dailyOral route1964-03-09activeS
Cholecalciferol (vitamin D3) 25 mcg (1000 units) oral tablet, one tablet by mouth dailyOne tablet dailyOral route1964-05-11activeS

Allergies and Intolerances

AllergyReactionStatusEvidence
No known allergyactiveS

Vital Signs

DateMeasureValueUnitProvenance
1964-10-05Body height170cmS
1964-10-05Body weight92.2kgS
1964-10-05Body mass index (BMI) [Ratio]31.9kg/m2S
1964-10-05Systolic blood pressure128mm[Hg]S
1964-10-05Diastolic blood pressure80mm[Hg]S
1964-10-05Heart rate66/minS
1964-10-05Respiratory rate16/minS
1964-10-05Body temperature36.7CelS
1964-10-05Oxygen saturation in Arterial blood by Pulse oximetry98%S

Results

DateMeasureValueUnitReference rangeFlagProvenance
1964-10-05Cholesterol [Mass/volume] in Serum or Plasma204mg/dL<=200 mg/dLHighS
1964-10-05Cholesterol in HDL [Mass/volume] in Serum or Plasma54mg/dL>=50 mg/dLNormalS
1964-10-05Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation126mg/dL<=129 mg/dLNormalS
1964-10-05Triglyceride [Mass/volume] in Serum or Plasma118mg/dL<=149 mg/dLNormalS
1964-10-05Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]3{score}S

Physical Exam

Vital signs recorded on 1964-10-05; see the Vital Signs section. [S]

SystemFinding
ConstitutionalWell; weight 92.2 kg, BMI 31.9; blood pressure 128/80 (average of two)
EyesNo redness; pupils equal and reactive
Head, eyes, ears, nose, and throatNo thrush; voice clear
NeckNo lymph nodes; thyroid normal
BreastsExamined with her agreement and a chaperone: no mass, skin change or nipple discharge; no axillary nodes
CardiovascularRegular rhythm; no murmur; defibrillator pocket healed; no ankle swelling
RespiratoryClear to auscultation bilaterally
AbdomenOld lower midline scar; soft; no liver or spleen enlargement
PelvicSpeculum examination with her agreement and a chaperone: vaginal cuff healed, no cervix present
SkinNo rash, nodules or plaques; no suspicious lesions
MusculoskeletalHeight 170 cm, unchanged; no spinal tenderness
PsychiatricWarm, lively, engaged

Problems

ProblemClinical statusVerificationCodeProvenance
Breathlessness on exertion and a dry cough for three months, worse on tour, with tiredness and chest tightness; she can no longer hold long phrases; bilateral hilar lymph node enlargement on today's chest radiograph; granulomas were reported at an abdominal operation twelve years ago, with no pathology report available: sarcoidosis must be confirmed by tissue and other causes excludedresolvedconfirmed R06.09S — Synthetic presenting problem anchored to the documented breathlessness during performances and the 1952 granulomas. Superseded by the tissue diagnosis at the consultation.
Palpitations with two spells of light-headedness while singing; ECG today: sinus rhythm with first-degree atrioventricular block (PR 240 ms) and frequent ventricular ectopic beats: cardiac involvement must be looked forresolvedconfirmed R00.2S — Synthetic finding; superseded when cardiac sarcoidosis was diagnosed.
Hypercalcemia: calcium 10.8 mg/dL with a high 1,25-dihydroxyvitamin D and a low 25-hydroxyvitamin D, while taking an over-the-counter calcium and vitamin D supplement; creatinine slightly raisedresolvedconfirmed E83.52S — Synthetic finding; resolved on treatment.
Pulmonary sarcoidosis with hilar and mediastinal lymph node involvement (Scadding stage II), confirmed by non-necrotizing granulomas on EBUS-guided lymph node aspiration with negative stains and cultures; mild restriction and reduced diffusing capacity; synthetic modern detail linked to her documented sarcoidosisactiveconfirmed D86.2S — Synthetic histology, stage and lung function; her biographer reports a diagnosis of sarcoidosis after granulomas were found at an operation (D, probable).
Acute viral laryngitis: three days of hoarseness, a sore throat and a mild dry cough after a cold, without fever, on prednisone 20 mg and methotrexate; rapid influenza and COVID-19 tests negative; no thrush; resolvedresolvedconfirmed J04.0S — Synthetic acute infection; not a historical claim.
Cardiac sarcoidosis: first-degree atrioventricular block, ventricular ectopy (6 percent of beats) with nonsustained ventricular tachycardia, left ventricular ejection fraction 47 percent, patchy late gadolinium enhancement of the basal septum and inferolateral wall, and matching focal FDG uptake on PET; synthetic modern detail linked to the documented private account that sarcoidosis was in her heartactiveconfirmed D86.85S — Synthetic cardiac findings; the account that her doctors told her sarcoidosis was in her heart rests on her biographer (D, probable), and the interpretation of her later heart disease is R.
Long-term systemic glucocorticoid treatment for sarcoidosis, with bone, glucose, blood pressure, infection and eye risks to manageactiveconfirmed Z79.52S — Synthetic treatment status.
Dual-chamber implantable cardioverter-defibrillator, placed after sustained monomorphic ventricular tachycardia was induced at electrophysiology study; remote monitoringactiveconfirmed Z95.810S — Synthetic device status after the synthetic implant.

Assessment and Plan

Personalized prevention plan. A written copy was given to the patient. [S]

ServiceStatusDetail
Blood pressure screeningCompleted today128/80 mmHg, lower than on high-dose prednisone
Depression screeningCompleted todayPHQ-9 score 3; item 9 scored 0
Unhealthy alcohol use screeningCompleted todayNo alcohol
Tobacco useCompleted todayNever smoked
Intimate partner violence screeningCompleted todayNegative; she feels safe
Breast cancer screeningOrderedMammogram every two years from 40; last one three years ago; ordered today
Colorectal cancer screeningUp to dateColonoscopy six years ago normal; next due in four years
Cervical cancer screeningNot indicatedNo cervix on examination today after hysterectomy, and no history of cervical precancer
Diabetes screeningCompleted todayA1c 6.2% in August: prediabetes; diabetes prevention program offered
Cholesterol screening and statin decisionCompleted todayTotal cholesterol 204, HDL 54, LDL 126 mg/dL; ten-year risk about 4 percent; no statin now
Osteoporosis screening and glucocorticoid bone protectionUp to dateBone density in March, T-score -1.6; on alendronate; repeat in two years
HIV and hepatitis C screeningUp to dateBoth negative at the consultation in February
Influenza vaccineCompleted todayInactivated vaccine given
COVID-19 vaccineCompleted todayThis season's mRNA vaccine given
Pneumococcal vaccineUp to datePCV20 in March, before immunosuppression
Recombinant zoster vaccineUp to dateTwo doses, March and August
Hepatitis B vaccineUp to dateTwo-dose adjuvanted series completed in May
Tetanus, diphtheria, and pertussisUp to dateTdap six years ago
Live vaccines (MMR, varicella)Not indicatedAvoided on prednisone and methotrexate
Eye examinationUp to dateOphthalmology in March normal (no uveitis); yearly while on glucocorticoids and with sarcoidosis
Dental examinationDueBefore the autumn tour; alendronate noted for the dentist

Immunizations given today: Influenza vaccine, this season (inactivated); COVID-19 mRNA vaccine, this season's formula [S]

Guideline basis: Birnie DH, et al. HRS expert consensus statement on the diagnosis and management of arrhythmias associated with cardiac sarcoidosis. Heart Rhythm 2014;11(7):1305-1323 (PMID 24819193) (2014); Humphrey MB, et al. 2022 American College of Rheumatology Guideline for the Prevention and Treatment of Glucocorticoid-Induced Osteoporosis. Arthritis Rheumatol 2023;75(12):2088-2102 (PMID 37845798) (2022); Adult Immunization Schedule by Medical Condition and Other Indication (2026); Medicare Preventive Services reference: visit templates, screening cascades, and documentation elements (2026); USPSTF A and B Recommendations (2026); Breast Cancer: Screening (2024); Statin Use for the Primary Prevention of Cardiovascular Disease in Adults: Preventive Medication (2022)

Follow-up: Mammogram within the month. Methotrexate blood tests next month. Pulmonology and cardiology as planned. Next preventive visit in one year. [S]

Advance Care Planning

Voluntary advance care planning discussion of about 30 minutes, with her consent. She named a health care agent, recorded in the confidential part of the chart and not named here, and completed a health care power of attorney. She said that her faith guides her, that she wants every treatment that gives her a good chance to live and to sing, and that if she became so ill that she could not recover to know and pray with the people around her, she would want comfort care and her church's prayers rather than machines. The defibrillator was explained: it can be switched off painlessly by the device team if she ever chooses comfort care at the end of life, and she asked that this be discussed with her agent then. To be revisited at each change in her health and at least yearly. [S]